The CDC issued framework for resuming safe and responsible cruise ship passenger operations
On Oct. 30, 2020, the Centers for Disease Control and Prevention (CDC) issued a Framework for Conditional Sailing…
Trials of University of Oxford’s Coronavirus vaccine began in Kenya
On Oct. 30, 2020, the University of Oxford announced that Kenya had joined the global efforts in search…
Humanigen announced first patient dosed in phase 3 clinical study of Lenzilumab in COVID-19
On Oct. 30, 2020, Humanigen announced that MedStar Washington Hospital Center in Washington, D.C. treated its first COVID-19…
Hologic awarded US Government contract to expand COVID-19 test production capacity
On Oct. 30, 2020, Hologic announced that it had been awarded a $119 million contract from the U.S….
Innovation Pharma and George Mason University released lab testing results for Brilacidinﾒs COVID-19 treatment
On Oct. 30, 2020, Innovation Pharma and George Mason University jointly announced completion of extensive laboratory testing supporting…
REGN-COV2 IDMC recommended holding enrollment in hospitalized patients with high oxygen requirements
On Oct. 30, 2020, Regeneron announced that ot had received a recommendation from the independent data monitoring committee…
Icosavax launched COVID-19 vaccine program with preclinical data and $165 million in new funding
On Oct. 30, 2020, Icosavax announced the launch of the companyﾒs COVID-19 vaccine program with preclinical data on…
InBios awarded $12.67 million DOD contract to Increase domestic production of rapid point of care COVID-19 tests
On Oct. 30, 2020 InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
The CDC opened new South America Regional Office in Brazil
On Oct. 29, 2020, the Centers for Disease Control and Prevention (CDC) opened its new South America regional…
Oxford University began COVID-19 test for individuals without symptoms
On Oct. 29, 2020, the University of Oxford announced a new pilot scheme to assess the use of…
OncoSec announced FDA clearance of IND application for phase 1 clinical trial of CORVax12 vaccine candidate for COVID-19
On Oct. 29, 2020, OncoSec Medical announced that the FDA had approved the Investigational New Drug (IND) application…
Humanigen announced first patient dosed in NIH ACTIV-5/Big Effect trial evaluating Lenzilumabﾙ for COVID-19
On Oct. 29, 2020, Humanigen announced that the first patient had been dosed at the Emory University School…
PerkinElmer COVID-19 test kit receives FDA Emergency Use Authorization for sample pooling
On Oct. 29, 2020, PerkinElmer announced that the FDA had issued Emergency Use Authorization (EUA) to allow sample…
Emulate collaborated with FDA to apply lung-chip to evaluate safety of COVID-19 vaccines
On Oct. 29, 2020, Emulate announced that it had entered into a Cooperative Research and Development Agreement (CRADA)…
Final NIH policy for data management and sharing released
On Oct. 29, 2020, the National Institutes of Health (NIH) announed that it will begin requiring most of…
Novartis announced collaboration with Molecular Partners to develop DARPinﾮ therapies against COVID-19
On Oct. 28, 2020, Novartis and Molecular Partners announced an option and license agreement to develop, manufacture and…
CVS Health expanded COVID-19 testing services with 1,000 rapid-result test sites
On Oct. 28, 2020, CVS Health announced plans to expand COVID-19 testing services currently offered at select CVS…
NIH scientists discovered key pathway in lysosomes that coronaviruses use to exit cells
On Oct. 28, 2020, researchers at the NIH announced that they had discovered a biological pathway that the…
Data for Lilly’s bamlanivimab (LY-CoV555) in COVID-19 outpatients published in NEJM
On Oct. 28, 2020, Eli Lilly announced the New England Journal of Medicine had published data from the…
First patients treated with the worldﾒs smallest heart pump, the 9Fr Impella ECP
On Oct. 28, 2020, Abiomed announced the first two patients were treated with the Impella ECP expandable percutaneous…
UNMC VA study found contaminants may increase risk of rheumatoid arthritis
On Oct. 28, 2020, researchers at the University of Nebraska Medical Center (UNMC) reported the results of a…
Regeneron’s COVID-19 outpatient trial demonstrated that REGN-COV2 antibody significantly reduced virus levels
On Oct. 28, 2020, Regeneron announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the…
Aurinia announced European trial to evaluate antiviral activity of Voclosporin in kidney transplant recipients with COVID-19
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
Nektar Therapeutics announced phase 1b clinical study to evaluate empegaldesleukin for treatment of patients with COVID-19
On Oct. 27, 2020, Nektar Therapeutics announced that it has received FDA clearance for an Investigational New Drug…
Additional COVID-19 related genes ﾖ both helpful and harmful ﾖ revealed in massive screen
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
CHF Solutions announced deployment of Aquadex Systems to hospitals in the s to treat COVID-19 patients
On Oct. 27, 2020, CHF Solutions announced that it had shipped Aquadexﾙ product to medical facilities in Tennessee…
Antibodies co-invented by Scripps Research and IAVI developed as a potential COVID-19 therapy
On Aug. 27, 2020, immunologists at Scripps Research, in partnership with colleagues at the IAVI Neutralizing Antibody Center,…
Bayer acquired Asklepios BioPharmaceutical for $40 billion
On Oct. 26, 2020, Bayer announced the acquisition of Asklepios BioPharmaceutical, a North Carolina-headquartered biopharmaceutical company specialized in…
ContraFect initiated expanded access to Exebacase for treatment of MRSA bloodstream infections in COVID-19 patients
On Oct. 26, 2020, ContraFect announced that it had initiated an expanded access program to provide exebacase for…
Taconic Biosciences launched critical model for COVID-19 research
On Oct. 26, 2020, Taconic Biosciences announced immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2…